Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- Check2 days agoChange DetectedRemoves the melanoma reference from the study page’s content. Eliminates the Related topics section, including the MedlinePlus Genetics link.SummaryDifference0.2%

- Check9 days agoChange DetectedNew related topics 'Melanoma' and 'MedlinePlus Genetics' were added, and the revision tag was updated from v3.6.2 to v3.6.3.SummaryDifference0.3%

- Check17 days agoChange DetectedThe page's revision metadata was updated from v3.6.0 to v3.6.2, indicating an updated release of the document.SummaryDifference0.1%

- Check31 days agoChange DetectedAdds a recruitment status notice and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the Intervention/Treatment label, reflecting a UI/structure change to the page.SummaryDifference0.7%

- Check38 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page's content or formatting.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded 'Melanoma' as a related topic and introduced a 'related topics' section featuring MedlinePlus Genetics, providing additional context and external references for readers.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.